Donald Abrams, MD
Dr. Abrams conducts clinical research of the use of cannabidiol for pain and symptom management, including for patients with sickle cell disease and chronic pain. He is also conducting an observational analysis of patients in San Francisco, San Diego and Chicago using cannabidiol-dominant products. Participants attending the integrative medicine center clinics in those cities as well as those at 3 dispensaries in each city to determine what they were using, how they were using it, for what and if it worked.
Stacey Anderson, PhD
Public health policy and social cognition focusing on investigating marketing strategies that tap implicit constructs of self and perceptions of others, pair brand identities with personal identities, and encourage consumption of products detrimental to individual and public health.
Dorie Apollonio, PhD
Health policy and tobacco control, particularly the ways that clinical research is translated into policy interventions and public knowledge.
Mehrdad Arjomandi, MD
Physiologic and inflammatory mechanisms of airway remodeling in various exposure-response models such as ozone-induced oxidative injury, allergic airway inflammation, and wood or tobacco smoke-induced airway injury.
John Balmes, MD
Respiratory and cardiovascular health effects of various air pollutants, focusing on the airway inflammatory effects of ozone, secondhand tobacco smoke, and wood smoke.
Neal Benowitz, MD
Human pharmacology of nicotine in relation to addiction and the pathogenesis of and individual differences in vulnerability to tobacco-related disease, and the use of pharmacologic data as a basis for public health policies to prevent and reduce such disease.
Stella Bialous, RN, DrPH, FAAN
WHO Framework Convention on Tobacco Control, tobacco industry monitoring and building nurses’ capacity for tobacco control nationally and internationally.
Paul Blanc, MD
Toxic exposures and illness with focus on the role of environmental factors and disease prevention if factors were eliminated.
Mai-Khanh Bui-Duy, MD
Improving chronic disease management and interdisciplinary care and education as well as transitions from acute/post-acute settings back to primary care.
Esteban G. Burchard, MD, MPH
Identify and characterize genetic, environmental and social factors that predispose to asthma and modify drug response with special interest in how racially-specific genetic differences that modify disease and response to treatment.
Pages
Center Leadership
Stanton A. Glantz, PhD
Director, Center for Tobacco Research Control & Education
Pamela Ling, MD MPH
Fellowship Program Director
Joe Guydish, PhD
Co-Director, Helen Diller Comprehensive Cancer Center Tobacco Control Program
Research Spotlight
Cigarette smoking among U.S. adolescents has declined, but similar declines have not occurred in youth smokeless tobacco (ST) use.